| 产品描述: | Apecotrep (TRPC6-IN-3) (compound 17) is a potent, orally active transient receptor potential C6 ion channel (TRPC6) inhibitor. Apecotrep modulates not only intracellular calcium concentration, but also membrane potential by modulating the flux of cations including calcium and sodium ions. Apecotrep can be used in research of respiratory system. |
| 体外研究: |
Apecotrep (TRPC6-IN-3) (compound 17;1-10 mg/kg;口服;分别于 LPS 刺激前 12 小时和 2 小时口服;LPS 诱导小鼠) 可抑制 LPS 诱导的血管渗漏,并抑制小鼠支气管肺泡灌洗蛋白 (BALF 蛋白) 的积聚模型。 Apecotrep (3 mg/kg;口服;每日一次,连续 4 天;感染 H1N1 病毒的小鼠) 可减少小鼠模型中 H1N1 病毒引起的血管渗漏。 |
| 参考文献: |
1. Thierry B, et, al. Inhibitors of TRPC6 for treating respiratory conditions. WO2021209510. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.362 ml |
11.808 ml |
23.616 ml |
| 5 mM |
0.472 ml |
2.362 ml |
4.723 ml |
| 10 mM |
0.236 ml |
1.181 ml |
2.362 ml |
| 50 mM |
0.047 ml |
0.236 ml |
0.472 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |